1
项与 212Pb-Pentixather 相关的临床试验Phase 1 Trial of Dosimetry Guided 212Pb-pentixather Radioligand Therapy in Patients With Atypical Lung Carcinoids and Neuroendocrine Carcinomas
This is a first-in-human clinical trial evaluating the safety of an alpha-radiation treatment (Lead-212 labelled Pentixather) in patients who have been diagnosed with, and previously treated, for atypical carcinoid lesions of the lung.
100 项与 212Pb-Pentixather 相关的临床结果
100 项与 212Pb-Pentixather 相关的转化医学
100 项与 212Pb-Pentixather 相关的专利(医药)
100 项与 212Pb-Pentixather 相关的药物交易